Rating History for BridgeBio Pharma (BBIO) by Morgan Stanley

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
5/8/2026 Sean Laaman Maintain Overweight
(N/A)
94.00
(98.00)
 
 
  Details